International Cancer Research Conference
March 24-26, 2025 | Singapore
Gut microbiota implications in Cancer
Cancer is a complex disease that is the world's second biggest cause of mortality. Numerous studies in recent years have underlined the dual significance of the gut microbiota in sustaining the health of the host. The term "gut microbiota" refers to the diverse population of commensal microorganisms, mainly bacteria but also fungi, archaea, and viruses that populate the intestinal tract, particularly the large intestine, and it can be thought of as one factor to which we are constantly exposed, at high doses, throughout our lives. The gastro-intestinal resident bacteria and the human body interact at a sophisticated level in the gut. Gut bacteria can produce a variety of metabolites and bioproducts that help to maintain homeostasis in both the host and the gut.
- Gut Microbiota and Host’s Tumorigenesis
- Microbial biomarkers
- Gut Microbiota and the Inflammasomes
- Faecal Microbiota Transplantation (FMT)
- Probiotics in Cancer
- Bacteria Based Therapies
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Jianhua Luo
University of Pittsburgh, United States
Kaushala Prasad Mishra
Asian Association for Radiation Research (AARR), India
Ibrahim El Bayoumy
Consultant of public health-Ministry of Health, Kuwait
Özlem Terzi
Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Turkey
Andrea González Báez
Autonomous University of Nuevo Leon, MexicoSubmit your abstract Today
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title :
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates